All Stories

  1. Characteristics of Adults With Addictions and Mental Health Problems Who Have Experienced Homelessness: A Population-Based Study From Alberta, Canada: Caractéristiques des adultes aux prises avec des problèmes de dépendance et de santé mentale et ayant...
  2. Integrated Management of Co-Occurring Alcohol Use Disorder and Depression: Clinical Approaches for Concurrent Disorders
  3. Emerging pharmacological strategies for the treatment of cannabis use disorder
  4. The Unseen Addiction: Improving Surveillance and Governance of Medical Cannabis in Canada
  5. Limitations and Future Directions in Pharmacological Treatment for Amphetamine-Type Stimulant Use Disorder
  6. What Psychiatrists Should Know About Prescribed Safer Opioid Supply
  7. Postdischarge Mortality in a Cohort Hospitalized With Anorexia Nervosa
  8. Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial
  9. Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review
  10. Associations between Gender Expression, Protective Coping Strategies, Alcohol Saliency, and High-Risk Alcohol Use in Post-Secondary Students at Two Canadian Universities
  11. Associations between Gender Expression, Protective Coping Strategies, Alcohol Saliency, and High-Risk Alcohol Use in Post-Secondary Students at Two Canadian Universities
  12. Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis
  13. Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
  14. Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders
  15. Implications of Cannabis Legalization on Substance-Related Benefits and Harms for People Who Use Opioids: A Canadian Perspective
  16. Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada
  17. The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial
  18. Ketamine for the treatment of major depression: a systematic review and meta-analysis
  19. Ways to get a more balanced gender representation in addiction journals’ management and workforce
  20. Cases: Multiorgan failure in a 38-year-old man with recent consumption of kratom, an atypical opioid
  21. The Effectiveness of Inpatient Addiction Consult Services: A Systematic Review and Narrative Synthesis
  22. Guilty until proven innocent
  23. Assessing research competency development in Canadian psychiatry residency programs: A systematic review and future directions
  24. Association Between Substance Use and Professional Outcomes Among Medical Students: Findings from a Canadian Cross-sectional Survey
  25. Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities
  26. Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?
  27. Psychological interventions for post-traumatic stress injuries among public safety personnel: a systematic review and meta-analysis
  28. Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis
  29. The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment
  30. The critical role of peer reviewers: Challenges and future steps
  31. Factors Associated With Past-year and Lifetime Prevalence of Cannabis Withdrawal: A Secondary Analysis
  32. Trends in Canadian Cannabis Consumption Over Time: A Two-step Meta-analysis of Canadian Household Survey Data
  33. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis
  34. Management of Post-Acute Alcohol Withdrawal: A Mixed-Studies Scoping Review
  35. Neurobiology and Symptomatology of Post-Acute Alcohol Withdrawal: A Mixed-Studies Systematic Review
  36. Exclusion of the non-English-speaking world from the scientific literature: Recommendations for change for addiction journals and publishers
  37. Challenges and opportunities for further research involving the cannabis‐to‐opioid use transition
  38. Self-Reported Cannabis Use and HIV Viral Control among Patients with HIV Engaged in Care: Results from a National Cohort Study
  39. Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta‐analysis
  40. Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review
  41. Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
  42. Comment on “I’m Virtually a Psychiatrist: Problems with Telepsychiatry in Training”
  43. Patients With Infective Endocarditis Deserve Evidence-based Addiction Treatment
  44. Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders
  45. The Prevalence of Impulse Control Disorders and Behavioral Addictions in Eating Disorders: A Systematic Review and Meta-Analysis
  46. Considering Cannabis Use in Differential Diagnosis
  47. Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia
  48. The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis
  49. Prevalence of and Factors Associated With Substance Use Among Canadian Medical Students
  50. What are the clinical implications of Bahá’í perspectives of psychiatry and mental health?
  51. Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis
  52. Genetic markers of the stress generation model: A systematic review
  53. Comparative efficacy and safety of stimulant-type medications for depression: A systematic review and network meta-analysis
  54. Concurrent Disorders Management in Psychiatric Care: Opportunities and Challenges
  55. The Prevalence of Cannabis Use Disorder Comorbidity in Individuals With Bipolar Disorder: A Systematic Review and Meta-Analysis
  56. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium
  57. Supporting Persons Who Use Drugs During the COVID-19 Pandemic: A Rapid Review of International Guidelines
  58. Towards competency-based medical education in addictions psychiatry: a systematic review
  59. Ketamine for Bipolar Depression: A Systematic Review
  60. Proactive psychological programs designed to mitigate posttraumatic stress injuries among at-risk workers: a systematic review and meta-analysis
  61. Comparative Efficacy and Acceptability of Psychotherapies for Self-harm and Suicidal Behavior Among Children and Adolescents
  62. Making a case for the inclusion of refractory and severe mental illness as a sole criterion for Canadians requesting medical assistance in dying (MAiD): a review
  63. Misuse and dependence of dimenhydrinate: A mixed studies systematic review
  64. Transcranial direct current stimulation for empathy: A systematic review and meta-analysis
  65. Psychological interventions for posttraumatic stress injuries among public safety personnel: a systematic review and meta-analysis
  66. Coping among public safety personnel: A systematic review and meta–analysis
  67. Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse?
  68. Policy Brief: CSAM in Support of the Decriminalization of Drug Use and Possession for Personal Use
  69. Recent Advances in Biomarkers of Addiction: A Narrative Review
  70. Erratum to “Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis” [Journal of Affective Disorders 278C (2021) 542–555]
  71. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
  72. Response to Canadian Psychiatric Association Cannabinoid Products Position Statement: Potential for Ameliorating Cannabis Withdrawal
  73. Alcohol-Related Psychiatric Presentations at a University-Affiliated Emergency Department: A Descriptive Prevalence Study
  74. Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis
  75. COVID-19 and the Need for Leadership Training in Psychiatry
  76. The Substance Treatment and Recovery Team (START): Measuring the effectiveness and feasibility of an inpatient addiction consult service at an academic general hospital
  77. Efficacy and acceptability of cannabinoids for anxiety disorders in adults: A systematic review & meta-analysis
  78. The Addictive Nature of Compulsive Sexual Behaviours and Problematic Online Pornography Consumption: A Review
  79. Response to Canadian Psychiatric Association Opioid Use Disorder Position Statement: More than Just Collaborators in Care
  80. The Impact of Community Treatment Orders on Substitute Decision Makers
  81. Predictors of hospital admission for patients presenting with psychiatric emergencies: A retrospective, cohort study
  82. Virtual psychiatric care for older adults in the age of COVID‐19: Challenges and opportunities
  83. How to Serve the Underserved: Making the Case for Rural and Remote Mental Health Training for Psychiatry Residents
  84. Harm Reduction for Injection Drug Users with Infective Endocarditis: A Systematic Review
  85. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis
  86. Effectiveness of Pharmacotherapies for Bipolar Depression: A Systematic Review & Network Meta-Analysis
  87. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids
  88. Incidence and Correlates of Cannabinoid-Related Psychiatric Emergency Care: A Retrospective, Multiyear Cohort Study
  89. Methamphetamine-Related Emergency Department Visits Requiring Psychiatric Admission: A Retrospective Cohort Study
  90. Mortality Among People With Opioid Use Disorder: A Systematic Review and Meta-analysis
  91. Commentary on Hayes et al. (2020): The harms of opioid dose escalation in the management of chronic non‐cancer pain
  92. Acknowledgement to Reviewers of JCM in 2019
  93. Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: a systematic review and meta‐analysis
  94. Systematic Review and Meta-Analyses of Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Reply to the Commentary by Jørgensen, Storebø, and Simonsen
  95. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis
  96. Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis
  97. Prevalence of intimidation, harassment, and discrimination in resident physicians: a systematic review and meta-analysis
  98. At-a-glance - The local response to the Canadian opioid epidemic in the Kingston, Frontenac, and Lennox and Addington communities
  99. 2.62 PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADOLESCENTS WITH SUBCLINICAL AND BORDERLINE PERSONALITY DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
  100. Psychotherapies for Adolescents with Subclinical and Borderline Personality Disorder: A Systematic Review and Meta-Analysis
  101. Reduction in mortality risk with opioid agonist therapy: a systematic review and meta‐analysis
  102. International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis
  103. What are the key considerations for clinicians treating Bahá'í patients with psychiatric disorders?
  104. Commentary on Stockings et al . (2019): The global amphetamine epidemic — a rising tide of mortality
  105. The Value of Hospitalization in the Opioid Epidemic
  106. Is stigma preventing knowledge translation and utilization of electroconvulsive therapy for depression?
  107. Management of endocarditis among persons who inject drugs: A narrative review of surgical and psychiatric approaches and controversies
  108. Piloting an Addictions Medicine Consultation Team in Kingston, Ontario, Canada
  109. Prevalence of substance use disorder comorbidity among individuals with eating disorders: A systematic review and meta-analysis
  110. Characterizing inpatient care for adults with schizophrenia using the Health Quality Ontario indices: A single-centre retrospective cohort study
  111. A Critical Review of Addictions Curriculum in Canadian Residency Programs
  112. ECT beyond unipolar major depression: systematic review and meta‐analysis of electroconvulsive therapy in bipolar depression
  113. The Emerging Epidemic of Male Me-Too
  114. Attitudes to antipsychotics: a multi-site survey of Canadian psychiatry residents
  115. Assessing the utility of drug screening in the emergency: a short report
  116. Episodic Behavioural Regression in an 8-Year-Old Female: Sequelae of 22q11.2 Duplication Syndrome
  117. A case for opioid education and training for medical students, residents, and allied health staff: response to “educational intervention for physicians to address the risk of opioid abuse”
  118. Endocarditis in the setting of IDU
  119. Opioids on Trial
  120. Why residents need more training in prescribing antipsychotics for people with Schizophrenia
  121. Increasing awareness about HIV prevention among young people who initiated injection drug use in a Canadian setting, 1988–2014